Latest Pharmaceuticals News
Future-proof your consulting career into 2024 and beyond
Q&A with Harvard Business School Healthcare Alumni Association and Columbia Business School…
Erleada’s Phase II Apa-RP trial showed promise in treating high-risk localized prostate cancer patients who previously underwent radical prostatectomy
Key findings include a 100% 24-month postoperative biochemical recurrence-free rate in patients…
FDA accepts Bristol-Myers Squibb’s biologics license application for subcutaneous Opdivo in all previous indications
Acceptance of the application is based on encouraging results from the Phase…
Pharma Pulse 5/8/24: 5 facts to know about HIV PrEP, OpenAI releases ‘deepfake’ detector and more
The latest news for those in the pharmaceutical industry.
From identity to margin: securing audience measurement in pharmaceutical marketing
The industry needs to find a way to balance consumer privacy with…
Planning for the unique challenges faced by cell and gene therapy developers
In an interview with Pharm Exec Associate Editors Don Tracy and Melissa…
